The global T-cell lymphoma market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was valued at USD XX million in 2015 and is forecasted to reach USD XX million by 2021.
Non-Hodgkin’s lymphoma caused by malignant T-Cell lymphocytes represent a smaller subset (about 15% in the US) of the known types of non-Hodgkin’s lymphoma – approximately 6,885 new cases are diagnosed, annually. Based on the (SEER) cancer registries, incidence rates for lymphoid neoplasms and Hodgkin lymphoma were found to be 2.09 and 2.71 per 100,000 people, respectively. Within T/NK-cell lymphoid neoplasms, incidence rates were highest for peripheral T-cell lymphoma (PTCL) (0.78), followed by mycosis fungoides/Sezary syndrome (0.54) and T/NK-cell lymphoid neoplasms, not otherwise specified (NOS) (0.49). The incidence of ATL was rare in the US (0.04). The most common PTCL subtype was PTCL-NOS (0.41), followed by anaplastic large cell lymphoma (ALCL) (0.28), cutaneous T-cell lymphoma (0.25), and angioimmunoblastic lymphoma (0.10). The remaining PTCL sub-types (subcutaneous panniculitis-like T-cell lymphoma, hepatosplenic T-cell lymphoma, enteropathy-type T-cell lymphoma) were rare and had incidence rates of 0.01 per 100,000 persons.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/220510 .
Global T-Cell Lymphoma – Market Dynamics
The report details several factors driving and restraining the market, some of which are discussed below.
Rising healthcare expenditure
Numerous chemotherapy agents driving the market
Reimbursement policies covering cancer therapies
Poor incidence rate
Low awareness about lymphoma and treatment options
Adverse side effects of the therapies
The global T-cell lymphoma market has been segmented by type of disease into extranodal T-cell lymphoma, cutaneous T-cell lymphoma, anaplastic large cell lymphoma, and angioimmunoblastic T-cell lymphoma. The market, by treatment type, is divided into radiotherapy, chemotherapy, stem cell transplantation, and surgery. The chemotherapy treatment includes major drugs such as Bexarotene (Targretin), Denileukin Diftitox (Ontak), Romidepsin (Istodax), And Vorinostat (Zolinza), among many others. The market has been geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World.
Purchase a copy of Global T-Cell Lymphoma Market visit @ http://www.orbisresearch.com/contact/purchase/220510 For more information contact email@example.com .
Some of the key players in the market are:
Johnson & Johnson Pharmaceutical Research & Development
What the Report Offers
Market definition, along with identification of key drivers and restraints for the market.
Market analysis with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
A comprehensive list of key market players, along with the analysis of their current strategic interests and key financial information.
An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain critical insight into the factors driving and restraining the market, in addition to opportunities, offered.
Get More Information of Global T-Cell Lymphoma Market Report @ http://www.orbisresearch.com/reports/index/global-t-cell-lymphoma-market-growth-trends-and-forecasts-2017-2022 .
Some points TOC:
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
1.7 Report Description
- RESEARCH METHODOLOGY
2.2 Analysis Methodology
2.3 Study Timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Model
2.4.4 Expert Validation
For any enquires before buying, connect with us @ firstname.lastname@example.org
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research